Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo

Main Category: Stem Cell Research
Article Date: 13 Sep 2013 – 1:00 PDT

Prof. Qingjun Zhang and team from the Department of Neurosurgery, Peking University People’s Hospital proposed that umbilical cord mesenchymal stem cells may have similar targeting capabilities for glioma.

Contact Our News Editors

Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide. Thus, novel therapeutic strategies must to be investigated for the development of a more effective treatment strategy. Stem cell-based therapies are emerging as novel cell-based delivery vehicle for therapeutic agents.

Current ratings for:
Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo

stem cells migrating

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

If you write about specific medications or operations, please do not name health care professionals by name.


stem cell research section for the latest news on this subject.

Please use one of the following formats to cite this article in your essay, paper or report:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Research, Neural Regeneration. “Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo.” Medical News Today. MediLexicon, Intl., 13 Sep. 2013. Web.
13 Sep. 2013. <http://www.medicalnewstoday.com/releases/265995.php>


Fan CG, Wang DL, Zhang QJ, Zhou JR. Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo. Neural Regen Res. 2013;8(22):2093-2102.

privacy policy for more information.

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

After contralateral ventricular administration, DiI-labeled umbilical cord mesenchymal stem cells migrated from the initial injection site towards the glioma (arrows), mainly distributing along the interface of tumor and normal brain parenchyma.

Credit: Neural Regeneration Research

These findings were published in the Neural Regeneration Research (Vol. 8, No. 22, 2013).

The researchers found that human umbilical cord mesenchymal stem cells demonstrated excellent glioma-specific targeting capacity in established rat glioma models after intratumoral injection or contralateral ventricular administration in vivo.

Please note: If no author information is provided, the source is cited instead.

Share this post:

If you are a possible stem cell patient, find ways to get a stem cell cure to have much better health and youthfulness

If you're a medical doctor and would like to learn and incorporate various stem cell treatments into your medical practice, be sure to get the proper stem cell medical training

Recent Posts